-
-
-
-
-
-
-
SeaStar Medical Holding Corp. (ICU) PT Lowered to $6 at Maxim Group
-
-
-
-
-
-
-
SeaStar Medical trial board recommends continuing kidney injury study
-
-
-
-
-
-
-
SeaStar Medical (ICU) Provides Update on Nasdaq Listing Status
-
-
-
-
-
-
-
SeaStar Medical (ICU): FDA Approves Feasibility Study with SeaStar Medical’s Selective Cytopheretic Device in Adults with Cardiorenal Syndrome
-
-
-
-
-
-
-
Nuwellis (NUWE) Marks First Commercial Sale of QUELIMMUNE Therapy to Cincinnati Children’s
-
-
-
-
430,632 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

